Back

Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Peter Rainer

BKH St Johann in Tirol, St Johann in Tirol (Austria)

18 More presentations in this session

Presentation thumbnail
International cardiovascular disease risk calculators do not identify high risk in young hodgkin lymphoma survivors
Doctor K. Piddock (Manchester, GB)
Abstract
Presentation thumbnail
Late adverse effects of residual platinum concentrations on cardiac function in testicular cancer survivors: a 30-year follow-up study
Doctor A. Bjerring (Oslo, NO)
Abstract Slides
Presentation thumbnail
The impact of stress myocardial blood flow as a very strong predictor for all-cause mortality, cardiovascular mortality and adverse cardiac and cerebrovascular event in hemodialysis population.
Doctor S. Ooshima (Nagoya, JP)
Abstract
Presentation thumbnail
Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention
Doctor S. Okuno (Amagasaki, JP)
Abstract Slides
Presentation thumbnail
Left ventricular global longitudinal strain to predict pulmonary edema in chronic kidney disease patients on haemodialysis
Doctor R. Rameshwar (Chennai, IN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources